openPR Logo
Press release

Renal Denervation Technologies Are Anticipated To Increase at a Prolific CAGR of 40% Over 2026

01-31-2023 02:26 AM CET | Health & Medicine

Press release from: fact.mr

Renal Denervation Technologies

Renal Denervation Technologies

The global renal denervation technologies market is anticipated to increase at a prolific CAGR of 40% over the 2022-2026 forecast period. The market is expected to secure a market value of around US$ 720 million by 2026, up from US$ 186 million in 2022.

Download Free Sample Copy of This Report:

https://www.factmr.com/connectus/sample?flag=S&rep_id=7587

Demand for radiofrequency-based technology is expected to increase at 35% CAGR over the coming years. It is anticipated that the excellent efficacy of radiofrequency-based technology, which has been demonstrated in various trials, would boost the significance of these devices across geographies.

High Patient Awareness Regarding Renal Denervation Systems

Renal denervation systems are a relatively new technology used to treat hypertension. Patients may not be aware of the potential benefits of this technology, or the risks associated with it. To increase patient awareness, healthcare providers should educate patients about the potential benefits and risks of renal denervation systems. This can be done through patient education materials, such as brochures or pamphlets, as well as through one-on-one conversations with healthcare providers.

Additionally, healthcare providers should encourage patients to ask questions and seek out additional information about renal denervation systems. Finally, healthcare providers should ensure that patients are aware of any potential side effects or complications associated with the procedure. By increasing patient awareness of renal denervation systems, healthcare providers can help ensure that patients make informed decisions about their health care.

Share Your Requirements & Get Customized Reports:

https://www.factmr.com/connectus/sample?flag=RC&rep_id=7587

Competitive Landscape

Renal denervation device manufacturers are requesting authorization to employ renal denervation systems and devices in clinical trials. A significant driver of the renal denervation industry is the rise in clinical trials for the treatment of diseases, including hypertension and blood pressure.

This increase in trials is anticipated to increase the demand for renal denervation and present new prospects for renal denervation companies.
For instance :

• In 2022, Microsoft, an American global technology business, partnered with Johnson & Johnson. As part of this partnership, Johnson & Johnson is set to use Microsoft's cloud computing capabilities to connect patients and surgeons in an ecosystem for digital surgery.

Key Companies Profiled:

• Medtronic
• Boston Scientific Corp.
• Symple Surgical, Inc.
• Terumo Corporation
• Ablative Solutions, Inc.
• Abbott Laboratories
• Renal Dynamics Limited
• Mercator MedSystems, Inc.
• ReCor Medical, Inc.

Full Access to this Report Is Available:

https://www.factmr.com/checkout/7587

Key Segments:

• By Product :

o Symplicity
o Vessix
o EnligHTN
o Paradise
o Iberis
o Others

• By Technology :

o Radiofrequency-based
o Ultrasound-based
o Micro-infusion-based

• By End User :

o Hospitals
o Specialty Clinics
o Research & Academic Institutes
o Ambulatory Care Centers

• By Region :

o North America
o Europe
o Asia Pacific
o Latin America
o Middle East & Africa

Questionnaire answered in the report include:

• How the industry has grown?
• What is the present and future outlook on the basis of region?
• What are the challenges and opportunities?
• Why the consumption in region?
• In which year segment is expected to overtake segment?

Explore Fact.MR's More Insights on the Healthcare Domain

Skincare Device Market: https://www.prnewswire.com/news-releases/sales-of-skincare-devices-to-surpass-uss-43-48-bn-as-prevalence-of-dermatological-diseases-increases-factmr-report-301506974.html

ENT Medical Devices Market: https://www.prnewswire.com/news-releases/ear-nose-throat-ent-medical-devices-manufacturers-target-applications-in-cataract--glaucoma-treatment-factmr-301262063.html

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of industry research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Renal Denervation Technologies Are Anticipated To Increase at a Prolific CAGR of 40% Over 2026 here

News-ID: 2905373 • Views:

More Releases from fact.mr

Bioelectric Catheters Market Poised to Surpass USD 9.7 Billion by 2035 Amid Growing Demand for AI-Driven and Minimally Invasive Cardiac & Neurological Interventions
10-08-2025 | Health & Medicine
Fact.MR
Bioelectric Catheters Market Poised to Surpass USD 9.7 Billion by 2035 Amid Grow …
The global Bioelectric Catheters Market is set to expand at an impressive CAGR of 10.4% between 2025 and 2035, rising from an estimated USD 3.6 billion in 2025 to reach USD 9.7 billion by 2035, according to the latest insights from Fact.MR. The market's rapid acceleration is attributed to the rising prevalence of cardiovascular and neurological diseases, increasing adoption of minimally invasive surgeries, and the integration of AI and IoT-enabled
AI-Based Spirometers Market Set to Surge to USD 536.9 Million by 2035 - Driven by AI Integration, Telehealth Expansion, and Preventive Respiratory Care
10-08-2025 | Health & Medicine
Fact.MR
AI-Based Spirometers Market Set to Surge to USD 536.9 Million by 2035 - Driven b …
The global AI-based spirometers market is on a strong growth trajectory, forecasted to climb from USD 89.7 million in 2025 to an impressive USD 536.9 million by 2035, according to a new study by Fact.MR. This growth, at a CAGR of 19.6%, underscores the transformative role of artificial intelligence (AI) in redefining respiratory diagnostics and patient monitoring worldwide. As healthcare systems globally shift toward preventive and precision medicine, AI-based spirometry devices
3D Printed Heart Valves Market: Japan to Record 13.7% CAGR Through 2035 | FactMR Report
3D Printed Heart Valves Market: Japan to Record 13.7% CAGR Through 2035 | FactMR …
The global 3D-printed heart valves market is expected to reach USD 568.2 Million by 2035, up from an estimated value of USD 150.6 Million in 2025. During the forecast period from 2025 to 2035, the industry is projected to expand at a CAGR of 14.2%. Market Overview The emergence of 3D printing technology has enabled the production of customized heart valves that closely replicate the structure and mechanical properties of natural human
Canada's Marine Valves and Actuators Market Set to Grow at 5% CAGR Through 2035 | FactMR Report
Canada's Marine Valves and Actuators Market Set to Grow at 5% CAGR Through 2035 …
The global marine valves and actuators market is projected to increase from USD 7.6 billion in 2025 to USD 12.7 billion by 2035, registering a compound annual growth rate (CAGR) of 5.3% during the forecast period. This steady growth is driven by factors such as expanding offshore exploration, increasing shipbuilding activities, and the growing adoption of automation and environmental compliance technologies within maritime operations. Market by Product Type The market is categorized

All 5 Releases


More Releases for Renal

Advancements in Renal Dialysis Equipment Trend: A Crucial Influence on the Renal …
What market dynamics are playing a key role in accelerating the growth of the renal dialysis equipment market? The escalating incidence of chronic kidney disease is projected to boost the expansion of the renal dialysis equipment market. Chronic kidney disease, a term that describes the slow and progressive decline of kidney function, can ultimately result in kidney failure and other severe health conditions. This disease is linked with several risk factors
Renal Osteodystrophy Market: An In-Depth Analysis
The Renal Osteodystrophy Market was valued at approximately USD 2.4 billion in 2023 and is projected to reach around USD 7.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2024 to 2032. Renal Osteodystrophy Market Overview The Renal Osteodystrophy Market is experiencing significant growth, driven by the increasing prevalence of chronic kidney disease (CKD) and the associated bone disorders. Advancements in diagnostic techniques have enhanced early
Shaping the Renal Dialysis Equipment Market in 2025: Advancements in Renal Dialy …
How Big Is the Renal Dialysis Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent years, the renal dialysis equipment market has seen robust growth. It's projected to increase from $19.52 billion in 2024 to $20.92 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.2%. Factors contributing to growth in the historic period include comprehensive training and support programs, substantial research and development
Transforming the Veterinary Renal Disease Market in 2025: Increasing Pet Ownersh …
"What Is the Expected Size and Growth Rate of the Veterinary Renal Disease Market? The market size for veterinary kidney diseases has seen profound growth recently. It is set to expand from $15.5 billion in 2024 to $16.63 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. Several factors contributed to this growth during the historical period, including heightened initiatives to increase disease awareness, a shift in
Renal Cancer Pipeline Outlook Report 2024
DelveInsight's, "Renal Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ Renal Cancer companies and 80+ pipeline drugs in the Renal Cancer pipeline landscape. It covers the Renal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Renal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways
Renal Biomarker Market to register a CAGR of 7.0% by 2026: Rising Prevalence of …
Future Market Insights delivers key insights on the global renal biomarker market in a new report titled “Renal Biomarker Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” In terms of revenue, the global renal biomarker market is projected to register a healthy CAGR of 7.0% over the forecast period. In this report, Future Market Insights throws light on the various factors and trends impacting market growth over the forecast period